Academic Health Center
Stay Connected
research-and-clinical-trials

Does accreditation impact centers of hematopoietic cell transplantation (HCT)?

There are two hematopoietic cell transplantation (HCT) center-accrediting organizations in the nation, the Foundation for the Accreditation of Cellular Therapy (FACT) and core Clinical Trial Network certification (CTN).

In a recent study conducted by Schelomo Marmor, PhD, M.P.H., from University of Minnesota Department of Surgery, Marmor assessed if these accreditations improved clinical care and survival for HCT, a complex treatment viable for several hematological disease groups.

Read more
research-and-clinical-trials

New findings in cell communication may contribute to new cancer treatments

Researchers from the University of Minnesota recently discovered cells directly transfer tumor-causing microRNAs via tunneling nanotubes. Intercellular communication among distant and proximal cells is vital to survival in multicellular organisms. This communication is also extremely important in understanding cancerous tumor growth.

Gastrointestinal oncologist Emil Lou, M.D., Ph.D., collaborated with assistant professor and microRNA expert Subree Subramanian, Ph.D., on the findings published in the journal Translational Research.

Read more
in-the-news

In the news: Tips for a good night’s sleep

It may be worth it to think twice before picking up your iPad, tablet or laptop computer before bedtime. Using technology devices with bright screens could negatively affect the amount of sleep we are getting, which in correlation affects our brain health.

In a recent interview with KARE 11, Michael Howell, M.D., director of the Sleep Medicine Fellowship at the University of Minnesota, shared five tips concerning how to get a better night’s sleep:

Read more
research-and-clinical-trials

Research snapshot: E-cigarettes may result in lower consumed toxicants for users, says new UMN research

E-cigarettes are a quickly growing market, and potentially for good reason. New research out of the Masonic Cancer Center, University of Minnesota shows the metabolized levels of disease-causing compounds are significantly lower in e-cigarettes than traditional cigarettes.

Read more
research-and-clinical-trials

Grant Announcement: University of Minnesota receives multimillion-dollar NIH grant to research new heart attack treatments

A University of Minnesota multidisciplinary research team was awarded $2.6 million by the National Institutes of Health (NIH) to investigate new treatments for heart attacks. The research will focus on myocardial ischemia and reperfusion injury, which account for over 300,000 deaths each year in the U.S.

Myocardial ischemia occurs when blood flow to the heart muscle is stopped by blocked coronary arteries. The cessation causes the death of heart muscle cells, called necrotic cell death. Instances of a severely blocked coronary artery can result in a heart attack.

Read more
news-and-notes

Top Five Medical Research Highlights for 2014

In 2014, the University of Minnesota Medical School published several groundbreaking medical discoveries. From unlocking questions about heart cells to a UMN health researcher getting rock star treatment in front of more than 20,000 screaming fans, here are a few highlights .

Read more